Connect with us

Cannabis News

New Ohio Senate Bill Would Ban Sale Of Intoxicating Hemp Products To People Under 21

Published

4 months ago

on

“Everyone agrees (inserting hemp products) are aimed at children, because the skates and Oreo cookies seem and without regulating … we have to play these things to be sick of children (and) to be sick.”

Megan Henry, by Ohio Capital Journal

Bill demora (d) introduced the bill that would prohibit the bill that would prohibit people under the age of 21 recently. Unlike others entered, this bill would only be directed to hemp and not change the voter marijuana law.

Ohio Senate Bill 266 would also prohibit sale of hemp products that have not been tested in the same rules such as Marijuana and would prevent the introduction of hemp products that are considered attractive “in accordance with the language of the invoice.

This bill would prohibit the sale of hemp intoxicating product, “with a realistic humanistic or fictional human or fictional or fruit characteristics, including artistic, caricature or cartoon surrender,” according to the language of the invoice.

“I put this bill that everyone agrees to get rid of things that are bad,” the demora said the Democratic State of Senegai. “Everyone agrees (inserting hemp products) are aimed at children, because the skates and Oreo cookies seem and without regulating … we have to play these things to be sick of children (and) to be sick.”

Ohio Gov. Mike Dewine (R) asked them in advance to regulate or prohibit legislators with Delta-8 thc products.

“It’s a tremendous problem,” he said he was talking on Monday. “There is no regulations. We need regulation. We need a legislature to take action for this. We are looking for it in some things that could be able to do without legislature.”

The demora believes that Marijuana and Kalamu products are needed separately.

“We hope this bill, if nothing else can agree on a thing, to get bad things from children’s hand and stop marketing children,” he said.

The 2018 farm invoice says that Kalamua can be grown legally if less than 0.3 percent.

Ohio Kalamu is one of the 20 states of non-regulations on products, according to the drug enforcement drugs at the University of Ohio, 2024, according to the study of the policy center.

This is a handful factor Calipu in the legislature of Ohio trying to regulate intoxicating products.

Ohio Senate 86 bill

Ohio Senate Bill 86 would ban sale of kalamu products for anywhere under 21, imposing 10 percent Regulation of Kalamu products tax and cannabinoid drinking products.

The invoice would require crusher products to sell adult use only in marijuana dispensaries, in CBD stores, comfort stores, smoking stores or gas stations instead of selling.

Kalamu products would require intoxicating products if products are tested and packaged, labeling and complying with advertising standards.

Republican Ohio state sens. Steve Huffman and Shane Wilkin SB 86, Effectively exceeded Ohio Senate in April.

Ohio Senate 56 bill

Ohio Senate 56. The invoice would regulate the poisoning hemp and the ohio marijuana laws would change.

Marijuana authorized dispensency would allow you to access the automated hemp products, test and fill in vessels, labeling and advertising requirements.

Huffman, the city of R-Tipp 56 introduced Ohio Trade Department of Hemp Products and Chanabinoids.

The invoice will also reduce marijuana marijuana marijuana from 90% to 70%, limit the number of assets of assets 400 and ban smoking and prohibiting in most public places.

SB 56 This year it passed in the Senate, but still must be made in the Committee of the Judiciary.

The honests of the honoring of the Jeans to legalize the citizens in 2023, with 57% of the voting, and sales began in August 2024.

Ohio legislators can change the law as a citizen initiative that it is not a constitutional correction.

Ohio House bill 160

Ohio House Bill 160 is mostly treated Potential changes in state marijuana lawsBut it is also a intoxicating Hamp supply, each Thc product can only be sold in the Dispensaries of the Regulated Marijuana of Ohio.

HB 160 marijuana registration would reduce up to 90% summaries to 70 percent, the number of marijuana dispensers in 350, and the packaged marijuana tax ticket will be directed to the general income of the state.

It would prohibit the use of marijuana in public spaces and provide a preliminary conviction for marijuana crimes.

It would also be illegal to buy Marijuana in another state and return to Ohio.

State Rep. Brian Stewart, R-Ashville, has entered HB 160So far he has had three hearings in the Ohio House Judiciary Committee.

This entry was published by Ohio Capital Journal for the first time.

Marijuana is possible with the help of readers. If you are based on journalism to defend cannabis, consider the commitment to Patreon every month.

Related Topics:
Continue Reading

Cannabis News

Greenhouses and more at Fruit Logistica Berlin

Published

17 hours ago

on

February 9, 2026

By











New varieties, new concepts, new packaging, new products, new faces – there was a lot to do in Berlin last week. And, new travel schedules too: due to the black ice, many visitors traveling by plane had to extend their stay or find an alternative mode of transport – or both.

Click here for the photo report.

© Arlette Sijmonsma | MMJDaily.com

Fortunately, our bus drivers got us home safely to the Netherlands, and we were able to take all the photos of the greenhouse suppliers, growers and other related parties, so take a seat and enjoy our Fruit Logistica photo report!

There will be more updates this week, as well as extensive reports from our international Freshplaza colleagues, focused on the fresh produce industry.

Click here for the photo report.










Continue Reading

Cannabis News

Alaska Government Task Force Recommends Legalizing Psychedelic Therapy Upon FDA Approval

Published

17 hours ago

on

February 9, 2026

By

An Alaska psychedelic task force is recommending that the state move forward with plans to provide regulated access to psychedelics if the federal Food and Drug Administration (FDA) allows medical use of substances such as psilocybin and MDMA.

According to a law approved in 2024, after working for about a year studying the issue, Alaska Legislative Task Force on Psychedelic Drug Regulation released its findings and recommendations on Thursday.

“Alaska has one of the nation’s highest rates of domestic violence survivors and combat veterans suffering from PTSD, and many Alaskans continue to struggle with traditional treatments,” Sen. Forrest Dunbar (D), the task force’s leader, said in a press release.

“Our approach to these new medical therapies must be properly and independently evaluated so that if the legislature were to make policy changes, we will do so with empirical data in a properly controlled environment,” the senator said.

The panel’s report lists a number of findings based on a review of the scientific literature and expert testimony. This includes findings that some psychedelics do indeed have “potential therapeutic uses” and that “there is a particular focus on the use of these therapies for veterans, survivors of assault and interpersonal violence, and others with post-traumatic stress disorder (PTSD).

Members emphasized the importance of delivering psychedelic therapies in partnership with “multiple types of providers” to provide comprehensive treatment, rather than leaving it up to the patient.

Among its recommendations, the task force said, “If psychedelic medical therapies are approved by the FDA, the state should take steps to allow them to be used in Alaska, rather than ban their use.”

Alaska regulators should also identify clinical task forces, “whose role is to regularly review up-to-date studies and the evidence base to make recommendations, and rely on those entities to provide ongoing guidance on the use of these therapies,” he said.

“As much as possible, reserve the use of state statute for broad enabling language and essential components of a regulatory structure, and leave most regulatory decisions to the appropriate boards and agencies,” another recommendation reads. “Regulations still require a robust public process to be approved, but they are more predictable and can be updated or changed more easily than statutory amendments that require legislative action.”

“The appropriate parameters for the use of these therapies are likely to change over time as the evidence base matures and FDA approval may be granted for multiple therapies,” he said.

If the FDA continues to approve any psychedelics for medical use, the panel said the Alaska State Board of Medicine should update its guidelines for prescribing controlled substances to include new therapies.

Additionally, if the FDA approves psychedelic drugs and the Drug Enforcement Administration (DEA) federally reschedules substances such as psilocybin, Alaska “should fully reflect federal programming and Risk Evaluation and Mitigation Strategies (REMS), without adding duplicative or conflicting state regulations, and follow the rules for determining whether a DEA license is required.” the report he says

“This approach respects federal science and facilitates access for patients and providers,” he continues.

Additionally, as lawmakers and regulators await a federal decision to advance psychedelic therapies, states should consider legislation to “incorporate the recommendations made in this report to encourage statewide implementation action.”

“Legislation on triggers would require addressing various process and regulatory issues, such as the role and involvement of professional licensing boards, state agencies, and the Controlled Substances Advisory Committee,” the task force said.

The report also says that psychedelic reform should include military veterans’ access to FDA-approved therapies, which could involve working with the US Department of Veterans Affairs (VA) to identify opportunities to participate in clinical trials and pilot programs using new drugs.

“The grant should be considered to ensure active efforts by the American Medical Association (AMA) and the Centers for Medicare and Medicaid Services (CMS) to develop billing codes that will promote sufficient reimbursement for the provision of psychedelic therapy, which are essential to ensure patient access post-FDA approval,” the panel said.

Rep. Justin Ruffridge (R), who also serves as co-chair of the psychedelic panel, said the task force “focused on preparing Alaska for potential federal approval of psychedelic therapies.”

“These recommendations came from months of collaboration and work by medical professionals, advocates and legislators who focused on patient safety, evidence-based care and access, especially for those who have not seen progress through traditional treatments,” he said.

So far two other states have facilitated fully functioning psychedelic programs. Oregon voters legalized the therapeutic psilocybin in 2020and Colorado’s program was approved at the ballot box in 2022, with the state’s governor signing the legislation a year later to create the regulatory framework for the program

Meanwhile, a campaign in Alaska announced in December that it did not get enough signaturesAn initiative to legalize some psychedelics like psilocybin and DMT on the 2026 state ballot.– but the activists have emphasized that “the work is far from over” as they focus on putting the reform measure before the voters in 2028.

“While we won’t be on the ballot in 2026, we’re still on track for 2028, and with the determination, focus and support of our community, we’ll continue to move forward,” Natural Medicine Alaska said in December. “This movement is gaining momentum every day. In fact, 65 percent of Alaskans support this initiative, and that number continues to grow.”

A pre-campaign policy outline explained that the proposal is “under construction”. The Natural Medicine Health Act of 2022 passed by Colorado votersunder last year facilitators administered the state’s first legal dose of psilocybin.

A 2024 poll found that nearly half (49.4 percent) of Alaskan adults would support a ballot measure more broadly. remove criminal penalties for the use of substances such as psilocybin mushrooms.

That support rose significantly—to nearly two-thirds (65 percent)—when participants were told that Alaska has high rates of mental illness that could be treated with psychedelics.

Photo elements courtesy of the user carlosemmaskype and Apollo.

Marihuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

Anti legalization group fails to collect signatures to roll back laws

Published

2 days ago

on

February 8, 2026

By











A Maine campaign seeking to significantly roll back the state’s marijuana law failed to submit signatures this week for the November 2026 ballot, meaning anti-cannabis activists will have to move to 2027 if they hope to get the issue before voters.

Amid criticism from reform advocates, industry players and some lawmakers for allegedly deceptive signature-gathering tactics, Mainers for a Safe and Healthy Future apparently couldn’t make the cut by the Feb. 2 deadline.

“Cannabis orders were not returned yesterday,” Assistant Secretary of State for Communications Jana Spaulding told Cannabis Business Times on Tuesday. In Maine, that doesn’t mean the campaign has to start from scratch, though, because they can still put the proposition on next year’s ballot. A Republican Maine lawmaker and marijuana industry advocates raised the alarm last month that prohibitionist campaigners were using deceptive petitions to get voters to sign the petition.

A video shared by Rep. David Boyer (R) appeared to feature an image and audio recording of a person gathering signatures for the ballot measure, in which he grossly misrepresented what the cannabis proposal would accomplish, saying its main goal was to ensure the product’s safety through improved testing.

Read more at Marijuana Moment










Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media